On January 7, 2022, Jeffrey Maranian notified Summit Therapeutics Inc. announced that he was resigning from his positions as VP Corporate Controller and Principal Accounting Officer of the Company, effective as of close of business on January 21, 2022. Mr. Maranian's resignation was a personal decision and is not the result of any disagreement with the Company. The Company intends to conduct a search of potential candidates to fill the positions of VP Corporate Controller and Principal Accounting Officer. Mr. Maranian will assist in the transition of his duties and responsibilities pursuant to a short-term consulting arrangement entered into
with the Company.